{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:24:05Z","timestamp":1793838245955,"version":"4.6.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.regg.2017.03.005","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T23:16:06Z","timestamp":1500333366000},"page":"317-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Uso de estatinas y riesgo de ca\u00eddas en ancianos: revisi\u00f3n sistem\u00e1tica de la literatura"],"prefix":"10.1016","volume":"52","author":[{"given":"Luis Carlos","family":"Venegas Sanabria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephany","family":"Barbosa Balaquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Suarez Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel Alberto","family":"Garc\u00eda Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto","family":"Cano Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regg.2017.03.005_bib0070","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Pedersen","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.regg.2017.03.005_bib0075","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"1","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.regg.2017.03.005_bib0080","first-page":"19","article-title":"Estatinas en adultos mayores, una poblaci\u00f3n creciente","volume":"56","author":"Andrea","year":"2013","journal-title":"Rev la Fac Med UNAM"},{"issue":"3 Suppl","key":"10.1016\/j.regg.2017.03.005_bib0085","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jacl.2014.03.004","article-title":"An assessment by the statin muscle safety task force: 2014 update","volume":"8","author":"Rosenson","year":"2014","journal-title":"J Clin Lipidol [Internet]"},{"key":"10.1016\/j.regg.2017.03.005_bib0090","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.regg.2017.03.005_bib0095","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/gerona\/60.3.324","article-title":"Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons","volume":"60","author":"Visser","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.regg.2017.03.005_bib0100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/gerona\/61.1.72","article-title":"Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort","volume":"61","author":"Newman","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci [Internet]"},{"key":"10.1016\/j.regg.2017.03.005_bib0105","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/jgs.12840","article-title":"Muscle strength and physical performance as predictors of mortality, hospitalization, and disability in the oldest old","volume":"62","author":"Legrand","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.regg.2017.03.005_bib0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijcard.2015.05.045","article-title":"Ischemic heart disease, prescription of optimal medical therapy and geriatric syndromes in community-dwelling older men: A population-based study","volume":"192","author":"Gnjidic","year":"2015","journal-title":"Int J Cardiol [Internet]."},{"key":"10.1016\/j.regg.2017.03.005_bib0115","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s40266-014-0225-x","article-title":"Medication-related fall incidents in an older, ambulant population: The B-PROOF Study","volume":"31","author":"Ham","year":"2014","journal-title":"Drugs Aging [Internet]."},{"key":"10.1016\/j.regg.2017.03.005_bib0120","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1445-5994.2011.02622.x","article-title":"Relationships between HMG-CoA reductase inhibitors (statin) use and strength, balance and falls in older people","volume":"42","author":"Haerer","year":"2012","journal-title":"Intern Med J [Internet]."},{"key":"10.1016\/j.regg.2017.03.005_bib0125","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/qjmed\/hcp093","article-title":"Statin therapy, muscle function and falls risk in community-dwelling older adults","volume":"102","author":"Scott","year":"2009","journal-title":"QJM [Internet]"},{"key":"10.1016\/j.regg.2017.03.005_bib0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/ptj\/83.3.237","article-title":"A physiological profile approach to falls risk assessment and prevention","volume":"83","author":"Lord","year":"2013","journal-title":"Phys Ther"}],"container-title":["Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211139X17300914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211139X17300914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T19:58:57Z","timestamp":1602532737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211139X17300914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0211139X17300914"],"URL":"https:\/\/doi.org\/10.1016\/j.regg.2017.03.005","relation":{},"ISSN":["0211-139X"],"issn-type":[{"value":"0211-139X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uso de estatinas y riesgo de ca\u00eddas en ancianos: revisi\u00f3n sistem\u00e1tica de la literatura","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.regg.2017.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 SEGG. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}